Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,883 46,128 46,246 43,663 49,471 49,830 - -
Change - -42.97% 0.25% -5.58% 13.3% 0.73% - -
Enterprise Value (EV) 1 80,616 45,956 45,198 40,285 45,843 46,199 44,635 42,819
Change - -42.99% -1.65% -10.87% 13.8% 0.78% -3.38% -4.07%
P/E 54.4x 30.6x 33.2x 10.6x 46.6x 34.8x 26x 23.2x
PBR 13.9x 7.82x 6.99x 4.36x 4.79x 4.7x 4.09x 3.79x
PEG - 12.14x -5.79x 0x -0.6x 1x 0.8x 1.9x
Capitalization / Revenue 15.5x 8.57x 7.7x 8.03x 8.15x 7.37x 6.7x 6.09x
EV / Revenue 15.4x 8.54x 7.53x 7.41x 7.56x 6.83x 6x 5.23x
EV / EBITDA 46.6x 23.7x 24.1x 24.1x 25.5x 21.7x 18.8x 16x
EV / EBIT 50.6x 25.6x 26.1x 26.6x 27.9x 23.5x 20.2x 17.3x
EV / FCF 57.3x 47.2x 47.9x 139x 34.3x 54.4x 27.7x 23.6x
FCF Yield 1.74% 2.12% 2.09% 0.72% 2.91% 1.84% 3.61% 4.25%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 2.38 2.44 2.3 6.97 1.83 2.486 3.322 3.733
Distribution rate - - - - - - - -
Net sales 1 5,232 5,382 6,005 5,440 6,068 6,763 7,433 8,185
EBITDA 1 1,729 1,936 1,879 1,670 1,800 2,131 2,378 2,680
EBIT 1 1,594 1,796 1,734 1,514 1,644 1,970 2,212 2,481
Net income 1 1,503 1,522 1,402 4,175 1,074 1,435 1,898 2,040
Net Debt 1 -267 -172.7 -1,048 -3,378 -3,628 -3,631 -5,195 -7,011
Reference price 2 129.55 74.61 76.25 74.03 85.25 86.45 86.45 86.45
Nbr of stocks (in thousands) 624,334 618,260 606,500 589,800 580,300 576,400 - -
Announcement Date 26/01/22 31/01/23 06/02/24 11/02/25 10/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
34.77x6.83x21.68x-.--% 49.83B
33.45x5.86x22.43x0.28% 249B
38.23x6.77x21.45x0.63% 158B
44.89x12.07x26.63x-.--% 148B
16.16x3.25x10.59x-.--% 62.32B
19.71x2.38x12.06x2.55% 49.61B
45.53x11.13x24.54x-.--% 48.14B
33.9x6.7x22.76x0.59% 49.06B
76.44x7.29x22.2x-.--% 42.9B
54.94x8.87x31.53x-.--% 41.04B
Average 39.80x 7.11x 21.59x 0.41% 89.82B
Weighted average by Cap. 38.00x 7.26x 22.05x 0.36%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Edwards Lifesciences Corporation

Historical PBR trend

Valuation ratios - PBR - Edwards Lifesciences Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Edwards Lifesciences Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Edwards Lifesciences Corporation


Year-on-year evolution of the Yield

Valuation ratios - Yield - Edwards Lifesciences Corporation
  1. Stock Market
  2. Stocks
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation